These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17678966)

  • 1. Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseases.
    Minghetti L; Pocchiari M
    Int Rev Neurobiol; 2007; 82():265-75. PubMed ID: 17678966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease.
    Walsh DT; Perry VH; Minghetti L
    Glia; 2000 Feb; 29(4):392-6. PubMed ID: 10652449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression and localization of cyclooxygenase-2 in astrocytes of scrapie-infected mice.
    Kim JI; Jin JK; Choi EK; Spinner D; Rubenstein R; Carp RI; Kim YS
    J Neuroimmunol; 2007 Jul; 187(1-2):74-82. PubMed ID: 17524497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
    Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
    Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia and prion disease.
    Brown DR
    Microsc Res Tech; 2001 Jul; 54(2):71-80. PubMed ID: 11455614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin.
    Tassorelli C; Greco R; Armentero MT; Blandini F; Sandrini G; Nappi G
    Int Rev Neurobiol; 2007; 82():373-82. PubMed ID: 17678972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells.
    Bate C; Kempster S; Williams A
    Neuropharmacology; 2006 Feb; 50(2):229-37. PubMed ID: 16289250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia and the pathogenesis of spongiform encephalopathies.
    Rezaie P; Lantos PL
    Brain Res Brain Res Rev; 2001 Mar; 35(1):55-72. PubMed ID: 11245886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of iNOS and COX-2 by a novel compound from Curcuma comosa in lipopolysaccharide-induced microglial activation.
    Thampithak A; Jaisin Y; Meesarapee B; Chongthammakun S; Piyachaturawat P; Govitrapong P; Supavilai P; Sanvarinda Y
    Neurosci Lett; 2009 Sep; 462(2):171-5. PubMed ID: 19583997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice.
    Riemer C; Schultz J; Burwinkel M; Schwarz A; Mok SW; Gültner S; Bamme T; Norley S; van Landeghem F; Lu B; Gerard C; Baier M
    J Virol; 2008 Dec; 82(24):12464-71. PubMed ID: 18842729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 derived from cyclooxygenases 1 and 2 mediates intestinal epithelial ion transport stimulated by the activation of protease-activated receptor 2.
    van der Merwe JQ; Ohland CL; Hirota CL; MacNaughton WK
    J Pharmacol Exp Ther; 2009 May; 329(2):747-52. PubMed ID: 19190238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
    Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
    Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells.
    Gonzalez-Rey E; Delgado M
    Brain Behav Immun; 2008 Jan; 22(1):35-41. PubMed ID: 17826030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activation.
    Thellung S; Villa V; Corsaro A; Pellistri F; Venezia V; Russo C; Aceto A; Robello M; Florio T
    Glia; 2007 Nov; 55(14):1469-85. PubMed ID: 17705195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Perineuronal Net in ME7 Prion Disease.
    Franklin SL; Love S; Greene JR; Betmouni S
    J Neuropathol Exp Neurol; 2008 Mar; 67(3):189-99. PubMed ID: 18344910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated manganese levels in blood and CNS in human prion disease.
    Hesketh S; Sassoon J; Knight R; Brown DR
    Mol Cell Neurosci; 2008 Mar; 37(3):590-8. PubMed ID: 18234506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGE(2) induces COX-2 expression in podocytes via the EP(4) receptor through a PKA-independent mechanism.
    Faour WH; Gomi K; Kennedy CR
    Cell Signal; 2008 Nov; 20(11):2156-64. PubMed ID: 18762248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The chronopathology of prion encephalopathies].
    Menéndez-González M; García-Fernández C; Suárez-San Martín E; Antón-González C; Blázquez-Menes B
    Rev Neurol; 2004 Nov 16-30; 39(10):962-5. PubMed ID: 15573315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-kappaB inhibition.
    Nam KN; Koketsu M; Lee EH
    Eur J Pharmacol; 2008 Jul; 589(1-3):53-7. PubMed ID: 18538761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases.
    Liberski PP; Sikorska B; Hauw JJ; Kopp N; Streichenberger N; Giraud P; Budka H; Boellaard JW; Brown P
    Virus Res; 2008 Mar; 132(1-2):226-8. PubMed ID: 18164506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.